StonvexLoading…
StonvexStonvexStonvexCore line items from ABX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $67.12M | $59.39M | $235.24M | $163.34M | $100.36M |
Operating Income | Not available | $18.33M | $88.76M | $65.96M | $43.55M |
Net Income | Not available | $7.27M | $36.53M | $29.30M | $22.22M |
EPS (Diluted) | $0.24 | $0.07 | $0.36 | $0.30 | $0.23 |
Total Assets | Not available | $829.79M | $902.24M | $918.94M | $848.36M |
Total Liabilities | Not available | $407.19M | $478.70M | $479.34M | $426.82M |
Cash & Equivalents | Not available | $37.21M | $38.11M | $86.42M | $74.84M |
Free Cash Flow OCF − CapEx | Not available | $91.55M | $-26.61M | $-19.06M | $13.86M |
Shares Outstanding | Not available | 95.98M | 97.47M | 97.70M | 91.82M |